Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Mast Cell Activation Disorders × 90 days × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 511 Neoplasms 444 Carcinoma, Non-Small-Cell Lung 355 Prostatic Neoplasms 319 Lung Neoplasms 255 Colorectal Neoplasms 243 Neoplasm Metastasis 201 Ovarian Neoplasms 175 Leukemia, Myeloid, Acute 175 Multiple Myeloma 170 Pancreatic Neoplasms 163 Stomach Neoplasms 133 Recurrence 128 Endometrial Neoplasms 124 Melanoma 123 Squamous Cell Carcinoma of Head and Neck 122 Brain Neoplasms 112 Carcinoma, Hepatocellular 110 Triple Negative Breast Neoplasms 109 Uterine Cervical Neoplasms 106 Precursor Cell Lymphoblastic Leukemia-Lymphoma 103 Lymphoma 102 Urinary Bladder Neoplasms 101 Glioblastoma 99 Head and Neck Neoplasms 93 Carcinoma, Renal Cell 88 Sarcoma 87 Hematologic Neoplasms 86 Lymphoma, Non-Hodgkin 81 Esophageal Neoplasms 78

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06186856 2026-03-05

DATAMAST

Imagine Institute

13,000 enrolled

Mast Cell Activation Disorders, Mastocytosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡